Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment – Eli Lilly and Company

Written by

admin

in

  1. Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment  Eli Lilly and Company
  2. Circle Pharma Announces Agreement with Lilly to Further Enhance AI/ML Capabilities and Accelerate Development of New Oral Macrocycle Therapies  Business Wire
  3. Eli Lilly launches platform for AI-enabled drug discovery  MarketScreener
  4. Lilly will let small biotechs use its AI models at no cost  statnews.com
  5. $1 Billion Worth of Drug Discovery Data: Eli Lilly Shares AI Models to Revolutionize Biotech Research  Stock Titan

Continue Reading

More posts